Results 111 to 120 of about 5,530 (216)
Modeling and parameter estimation for fractional large‐scale interconnected Hammerstein systems
Abstract This paper addresses the challenge of modeling and identifying large‐scale interconnected systems exhibiting memory effects, hereditary properties, and non‐local interactions. We propose a fractional‐order extension of the Hammerstein architecture that incorporates Grünwald–Letnikov operators to capture complex dynamics through multiple ...
Mourad Elloumi +2 more
wiley +1 more source
Transforming health systems in Tanzania towards universal health coverage: a scoping review of policy evolution, 1961-2025. [PDF]
Kiremeji M +14 more
europepmc +1 more source
Abstract Biomass gasification technology has been extensively researched around the world; however, there is a need to evaluate the current research landscape and evolutionary direction of research in the broader context of energy transition. A systematic bibliometric analysis of the Web of Science database was performed for articles that fall within ...
Olasunkanmi Opeoluwa Adeoye +5 more
wiley +1 more source
Demand-Side Management for a Decentralised and Equitable Energy Transition in Aotearoa New Zealand. [PDF]
Kamana-Williams B +3 more
europepmc +1 more source
Abstract Post‐harvest agricultural residues in Latin America are commonly underutilized, leading to greenhouse gas emissions and lost opportunities for bio‐based value creation. This study tests the hypothesis that decentralized, farmer‐scale pyrolysis technologies can deliver comparable agronomic benefits while exhibiting distinct techno‐economic and ...
Juan F. Saldarriaga +7 more
wiley +1 more source
Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trial. [PDF]
Kopanz J +6 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Decentralising drug-resistant TB treatment initiation services. [PDF]
Murphy-Okpala N +15 more
europepmc +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source

